Tetrous

Events

Oct 27-28, 2026

MNVC (Musculoskeletal New Ventures Conference)
Memphis, TN

Oct. 29 - 30, 2026 AOAO (American Osteopathic Academy of Orthopedics) Gaylord Resort, Chula Vista, CA Booth 307

Oct 29-31, 2026

AOAO (American Osteopathic Academy of Orthopedics)
Gaylord Pacific Resort, Chula Vista, CA
Booth 307

Nov. 11 - 14, 2026 SESA (Shoulder and Elbow Society of Australia) Geelong, Victoria, Australia

Nov 11-14, 2026

Geelong, Victoria, Australia
Feb. 5 - 6, 2027 Shoulder and Elbow Fellows & Young Surgeons IEP San Diego, CA Booth 11

Feb 5-6, 2027

Mar. 3 - 6, 2027 AAOS (American Academy of Orthopedic Surgeons) Las Vegas, NV Booth 5128

Mar 3-6, 2027

Mar. 12 - 15, 2027 ACFAS (American College of Foot & Ankle Surgeons) Orlando, FL Booth 2431

Mar 12-15, 2027

Apr. 30 - May 2, 2027 Shoulder 360 Miami Beach, FL Booth 3

Apr 30-May 2, 2027

Shoulder 360
Miami Beach, FL
Booth 3
May 13 - 15, 2027 AANA (Arthroscopy Association of North America) Hollywood, FL Booth 416

May 13-15, 2027

July 7 - 10, 2027 AOSSM (American Orthopedic Society for Sports Medicine) Boston, MA Booth 1130

Jul 7-10, 2027

Sep. 23 - 25, 2027 Pinnacle Shoulder Bend, OR

Sep 23-25, 2027

Bradley E. Patt, PhD

Dr. Patt is cofounder chairman of Tetrous.

Brad has over 40 years experience as an entrepreneur and executive manager. He has led several enterprises from start-up phase through rapid growth and merger and acquisitions.

Brad founded several high tech ventures since 1997. He is currently co-founder chairman and CEO of TheraCell and DermOQ. Previously he was co-founder, CEO and Chairman of Gamma Medica, Inc. Brad built Gamma to market leadership position in pre­clinical CT, PET, SPECT imaging and is inventor and developer of Molecular Breast Imaging for detecting otherwise occult breast cancer in dense­breasted women.

Brad is currently co­founder and Chairman of DermOQ, Inc., an oxygen skin care company; EVO Worldwide, Inc. and spin off Smart Breast Corp., medical diagnostic imaging systems companies; and Hyvida Brands, a functional beverage startup. He is a director of High Beauty a cannabis cosmetic company. Brad also founded and is a Director of Thrive Outside the Box, a nonprofit organization that identifies and develops areas of talent in individuals on the autistic spectrum.

Brad is an internationally recognized authority in the field of medical imaging with over one hundred scientific papers and presentations, several book chapters, and over 20 patents. He has been an invited speaker at several international conferences. He has held elected positions on the IEEE Nuclear Medicine Instrumentation Steering Committee (NMISC) and the IEEE Radiation Instrumentation Steering Committee (RISC), and was appointed to the Program Committee of the SPIE Medical applications of Penetrating Radiation, acting as Chairman of the Penetrating Radiation Work Group for 2003 and 2004. Dr. Patt is a consultant to the National Institutes of Health and the recipient of over $15 million dollars of grant awards as Principal Investigator from the National Institutes of Health, The United States Department of Energy and NASA.

Bradley E. Patt, PhD

Dr. Patt is cofounder chairman of Tetrous. Brad has over 40 years experience as an entrepreneur and executive manager. He has led several enterprises from start-up phase through rapid growth and merger and acquisitions. Brad founded several high tech ventures since 1997. He is currently co-founder chairman and CEO of TheraCell and DermOQ. Previously he was co-founder, CEO and Chairman of Gamma Medica, Inc. Brad built Gamma to market leadership position in pre­clinical CT, PET, SPECT imaging and is inventor and developer of Molecular Breast Imaging for detecting otherwise occult breast cancer in dense­breasted women. Brad is currently co­founder and Chairman of DermOQ, Inc., an oxygen skin care company; EVO Worldwide, Inc. and spin off Smart Breast Corp., medical diagnostic imaging systems companies; and Hyvida Brands, a functional beverage startup. He is a director of High Beauty a cannabis cosmetic company. Brad also founded and is a Director of Thrive Outside the Box, a nonprofit organization that identifies and develops areas of talent in individuals on the autistic spectrum. Brad is an internationally recognized authority in the field of medical imaging with over one hundred scientific papers and presentations, several book chapters, and over 20 patents. He has been an invited speaker at several international conferences. He has held elected positions on the IEEE Nuclear Medicine Instrumentation Steering Committee (NMISC) and the IEEE Radiation Instrumentation Steering Committee (RISC), and was appointed to the Program Committee of the SPIE Medical applications of Penetrating Radiation, acting as Chairman of the Penetrating Radiation Work Group for 2003 and 2004. Dr. Patt is a consultant to the National Institutes of Health and the recipient of over $15 million dollars of grant awards as Principal Investigator from the National Institutes of Health, The United States Department of Energy and NASA.